Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $10.50 USD
Change Today -0.12 / -1.13%
Volume 178.8K
TNDM On Other Exchanges
As of 8:10 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

tandem diabetes care inc (TNDM) Snapshot

Previous Close
Day High
Day Low
52 Week High
11/5/14 - $17.98
52 Week Low
07/2/15 - $10.20
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

tandem diabetes care inc (TNDM) Related Businessweek News

No Related Businessweek News Found

tandem diabetes care inc (TNDM) Details

Tandem Diabetes Care, Inc., a medical device company, focuses on the design, development, and commercialization of various products for people with insulin-dependent diabetes in the United States. The company offers t:slim insulin delivery system that comprises t:slim pump, its disposable insulin cartridge, and an infusion set; t:connect diabetes management application, a PC and Mac-compatible cloud-based data management application that provides a visual way to display therapy management data from the pump and supported blood glucose meters for users, their caregivers, and their healthcare providers; and t:flex insulin delivery system that includes 480-unit disposable insulin cartridge and an infusion set. Its products in development include t:slim G4TM insulin pump with an Integrated CGM system; Odyssey Web-based software that allows users to update their pump’s software in their home environment; t:sport insulin delivery system; automated insulin delivery, an artificial pancreas system with external device, or combination of devices, intended to aid a person with insulin-dependent diabetes by automatically testing and controlling their blood glucose; and t:dual infusion systems with dual-chamber infusion pump for the management of diabetes. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was founded in 2006 and is headquartered in San Diego, California.

437 Employees
Last Reported Date: 02/24/15
Founded in 2006

tandem diabetes care inc (TNDM) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $532.7K
Chief Financial Officer and Treasurer
Total Annual Compensation: $362.6K
Chief Operating Officer and Executive Vice Pr...
Total Annual Compensation: $347.1K
Chief Commercial Officer and Executive Vice P...
Total Annual Compensation: $347.1K
Chief Administrative Officer
Total Annual Compensation: $275.2K
Compensation as of Fiscal Year 2014.

tandem diabetes care inc (TNDM) Key Developments

Tandem Diabetes Care, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Reaffirms Earnings Guidance for the Full Year Ending December 31, 2015

Tandem Diabetes Care, Inc. announced unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported sales of $12,308,000 compared to $8,065,000 a year ago. Operating loss was $20,410,000 compared to $20,838,000 a year ago. Net loss was $21,208,000 or $0.83 per basic and diluted share compared to $21,962,000 or $0.96 per basic and diluted share a year ago. Operating loss included non-cash, stock-based compensation of $3.8 million for the quarter ended March 31, 2015, which was the same as the comparable period of 2014. For the year ending December 31, 2015, the Company affirms its prior guidance as follows: Sales are estimated to be in the range of $70.0 million to $75.0 million, which includes $1.0 million to $3.0 million of t:flex Insulin Pump sales; Operating margin is estimated to be in the range of negative 100% to negative 110%, which includes approximately $13.0 million to $14.0 million in non-cash, stock-based compensation expense.

Tandem Diabetes Care, Inc. Presents at Bank of America Merrill Lynch 2015 Health Care Conference, May-13-2015 10:00 AM

Tandem Diabetes Care, Inc. Presents at Bank of America Merrill Lynch 2015 Health Care Conference, May-13-2015 10:00 AM. Venue: Encore at the Wynn, 3131 S Las Vegas Blvd, Las Vegas, Nevada, United States. Speakers: Kim D. Blickenstaff, Chief Executive Officer, President and Director.

Tandem Diabetes Care, Inc. Commences Shipping t:slim Insulin Pump with Updated Software

Tandem Diabetes Care, Inc. commenced shipments of t:slim Pumps featuring enhanced software. The updated software, based on customer and healthcare provider feedback, includes an expansion of the reverse correction function, the ability to enter a manual bolus directly in the suggested bolus window, off-pump cartridge filling, and other features to enhance convenience and flexibility. Tandem is actively working on a project to provide current t:slim Pump users the ability to update their pump software remotely, similar to other modern consumer devices. The company plans to submit a filing for this remote update capability to the U.S. Food and Drug Administration later in 2015.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TNDM:US $10.50 USD -0.12

TNDM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $49.41 USD -0.11
Becton Dickinson and Co $143.18 USD -0.04
DexCom Inc $79.36 USD -0.41
Insulet Corp $29.78 USD -0.24
Smiths Group PLC 1,134 GBp -28.00
View Industry Companies

Industry Analysis


Industry Average

Valuation TNDM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.0x
Price/Book 3.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 3.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TANDEM DIABETES CARE INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at